2023 was a tough 12 months for the biopharma market, with many firms downsizing and restructuring their workforces to stay afloat. You'll find indications of recovery, as mergers and acquisitions picked up throughout the pharmaceutical and lifestyle sciences industry from the latter Section of 2023 and possess continued their upswing https://sites.google.com/view/bio-sites/blog